P04.27 Texture feature analysis to predict overall survival in recurrent glioblastoma treated in the DIRECTOR trial

Introduction: Recently, quantitative radiomics approaches have shown their potential to predict clinical outcome and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation status in patients with newly diagnosed glioblastoma. However, for recurrent glioblastoma scarce data on the value o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Vils, A., Wirsching, H., Nesteruk, M., Tanadini-Lang, S., Reifenberger, G., Tonn, J., Guckenberger, M., Wick, W., Andratschke, N., Weller, M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
POSTER PRESENTATIONS
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464162/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.167
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia